Joel Krikston

Principal, Venture Investments

Joel Krikston, Principal, Venture Investments, joined Johnson & Johnson Development Corporation (JJDC) in 2011. He is based in New Brunswick, New Jersey.

Prior to joining JJDC, Joel was Senior Director of Business Development for Johnson & Johnson Corporate Development working alongside JJDC, RedScript Ventures® LLC, Johnson & Johnson Corporate Office of Science and Technology (COSAT), and other partners in the identification, formation, development and launch of new businesses in emergent healthcare segments. Joel joined Ortho-Clinical Diagnostics (OCD) in 2006 as Director of Business Development and closed several transactions in support of OCD, Veridex and Therakos including a leading role on the acquisition of Immunicon in 2008.

Prior to joining Johnson & Johnson, Joel spent over 8 years as an investment banker, covering a wide range of healthcare clients and included experience at BNP Paribas, JPMorgan and ABN Amro. Joel has an MBA with honors from the Stern School of Business at NYU and completed his Bachelor’s degree in Finance and International Business at Fairfield University.